27824066|t|A Novel Insulin/Glucose Model after a Mixed-Meal Test in Patients with Type 1 Diabetes on Insulin Pump Therapy
27824066|a|Current closed-loop insulin delivery methods stem from sophisticated models of the glucose-insulin (G/I) system, mostly based on complex studies employing glucose tracer technology. We tested the performance of a new minimal model (GLUKINSLOOP 2.0) of the G/I system to characterize the glucose and insulin dynamics during multiple mixed meal tests (MMT) of different sizes in patients with type 1 diabetes (T1D) on insulin pump therapy (continuous subcutaneous insulin infusion, CSII). The GLUKINSLOOP 2.0 identified the G/I system, provided a close fit of the G/I time-courses and showed acceptable reproducibility of the G/I system parameters in repeated studies of identical and double-sized MMTs. This model can provide a fairly good and reproducible description of the G/I system in T1D patients on CSII, and it may be applied to create a bank of "virtual" patients. Our results might be relevant at improving the architecture of upcoming closed-loop CSII systems.
27824066	2	7	Novel	T080	C0205314
27824066	8	23	Insulin/Glucose	T081	C1719133
27824066	24	29	Model	T170	C3161035
27824066	38	53	Mixed-Meal Test	T059	C0202098
27824066	57	65	Patients	T101	C0030705
27824066	71	86	Type 1 Diabetes	T047	C0011854
27824066	90	102	Insulin Pump	T074	C1140609
27824066	103	110	Therapy	T061	C0087111
27824066	111	118	Current	T079	C0521116
27824066	119	155	closed-loop insulin delivery methods	T074	C0181334
27824066	194	222	glucose-insulin (G/I) system	T081	C1719133
27824066	224	230	mostly	T078	C0750554
27824066	240	247	complex	T080	C0439855
27824066	248	255	studies	T062	C0008972
27824066	256	265	employing	T033	C0557351
27824066	266	291	glucose tracer technology	T074	C0726401
27824066	296	302	tested	T169	C0039593
27824066	307	318	performance	T052	C1882330
27824066	328	341	minimal model	T170	C3161035
27824066	343	358	GLUKINSLOOP 2.0	T170	C3161035
27824066	367	377	G/I system	T081	C1719133
27824066	381	393	characterize	T052	C1880022
27824066	398	417	glucose and insulin	T081	C1719133
27824066	418	426	dynamics	T070	C3826426
27824066	434	442	multiple	T081	C0439064
27824066	443	459	mixed meal tests	T059	C0202098
27824066	461	464	MMT	T059	C0202098
27824066	469	478	different	T080	C1705242
27824066	479	484	sizes	T082	C0456389
27824066	488	496	patients	T101	C0030705
27824066	502	517	type 1 diabetes	T047	C0011854
27824066	519	522	T1D	T047	C0011854
27824066	527	539	insulin pump	T074	C1140609
27824066	540	547	therapy	T061	C0087111
27824066	549	589	continuous subcutaneous insulin infusion	T061	C0393124
27824066	591	595	CSII	T061	C0393124
27824066	602	617	GLUKINSLOOP 2.0	T170	C3161035
27824066	618	628	identified	T080	C0205396
27824066	633	643	G/I system	T081	C1719133
27824066	645	653	provided	T052	C1999230
27824066	673	676	G/I	T081	C1719133
27824066	677	689	time-courses	T079	C0449247
27824066	701	711	acceptable	T080	C1879533
27824066	712	727	reproducibility	T080	C1514863
27824066	735	745	G/I system	T081	C1719133
27824066	746	756	parameters	T033	C0449381
27824066	760	768	repeated	T169	C0205341
27824066	769	776	studies	T062	C0008972
27824066	780	789	identical	T080	C0205280
27824066	794	806	double-sized	T081	C0392762
27824066	807	811	MMTs	T059	C0202098
27824066	818	823	model	T170	C3161035
27824066	828	835	provide	T052	C1999230
27824066	867	878	description	T170	C0678257
27824066	886	896	G/I system	T081	C1719133
27824066	900	903	T1D	T047	C0011854
27824066	904	912	patients	T101	C0030705
27824066	916	920	CSII	T061	C0393124
27824066	936	943	applied	T169	C4048755
27824066	964	982	"virtual" patients	T058	C1553497
27824066	988	995	results	T034	C0456984
27824066	1005	1013	relevant	T080	C2347946
27824066	1017	1026	improving	T080	C1272745
27824066	1056	1067	closed-loop	T169	C0443183
27824066	1068	1072	CSII	T061	C0393124